Published time:2017-05-19
Document type:PDF
Language version:English/Chinese
Published by AskCI
No. | Content | Page |
---|---|---|
Executive Summary | ||
Methodology | ||
1 | Development Environment of Stem Cell Industry in China | |
1.1 | Economy | |
1.2 | Policy | |
1.3 | Society | |
2 | Development Status of Medical and Health Institutions in China, 2011-2016 | |
2.1 | Numbers of Institutions | |
2.2 | Numbers of Beds | |
2.3 | Numbers of Patients | |
2.4 | Numbers of Inpatients and Discharges | |
2.5 | Bed Utilization | |
3 | General Development of Stem Cell Industry in China, 2011-2016 | |
4 | Analysis of Key Enterprises in China Stem Cell Industry | |
4.1 | VCANBIO Cell & Gene Engineering Corporation, Ltd | |
4.2 | China Cord Blood Corporation | |
4.3 | Tianjin Amcellgene Engineering Co., Ltd. | |
4.4 | Beijing Health-Biotech Group | |
4.5 | Sichuan Neo-life Stem Cell Biotech Inc. | |
4.6 | Beike Biotechnology Co., Ltd. | |
4.7 | Shandong Qilu Stem Cell Engineering Co., Ltd. | |
4.8 | Beijing Jiachenhong Bio-tech Corp. Ltd. | |
4.9 | TongYuan Bio-Engineering Co., Ltd. | |
4.10 | Shanghai Stem Cell Technology Co., Ltd. | |
5 | Forecast and Investment Strategy of Stem Cell Industry in China, 2017-2022 | |
5.1 | Forecast | |
5.2 | Investment Strategy | |
5.2.1 | Meaning of Strategy Planning | |
5.2.2 | Principles of Strategy Planning | |
5.2.3 | Analysis on Strategy Planning | |
5.2.4 | Key Customer Strategy |
Figure No. | Figure Title |
---|---|
Figure 1 | China’s GDPs and growth rates, 2011-2016 |
Figure 2 | Investments in medical treatment informatization in China, 2012-2016 |
Figure 3 | Market scales of stem cell industry in China, 2011-2016 |
Figure 4 | Business distribution of VCANBIO Cell & Gene Engineering Corporation, Ltd in 2016 |
Figure 5 | Market scale forecast of stem cell industry in China, 2017-2022 |
Table No. | Table Title |
---|---|
Table 1 | China’s GDP distributions, 2014-2016 |
Table 2 | Related policies to stem cell industry in China |
Table 3 | Consumptions on medical and health care by urban and rural residents in China, 2012-2016 |
Table 4 | Numbers of medical institutions in China, 2011-2016 |
Table 5 | Numbers of beds in Chinese medical and health institutions, 2011-2016 |
Table 6 | Numbers of patients in Chinese medical and health institution, 2011-2016 |
Table 7 | Numbers of inpatients and discharges in Chinese medical and health institutions, 2011-2016 |
Table 8 | Bed utilizations in Chinese hospitals, 2011-2016 |
Table 9 | Revenues of VCANBIO Cell & Gene Engineering Corporation, Ltd by industries and products from Jan. to June in 2016 |
Table 10 | Revenues and profits of VCANBIO Cell & Gene Engineering Corporation, Ltd, 2012-2016 |
Table 11 | Regional revenues of VCANBIO Cell & Gene Engineering Corporation, Ltd in 2016 |
Table 12 | Revenues of China Cord Blood Corporation, FY2012-FY2016 |
Table 13 | Revenues and profits of Tianjin Amcellgene Engineering Co., Ltd., 2012-2015 |
Table 14 | Operation of Beijing Health-Biotech Group, 2014-2016 |
Table 15 | Stem cell services of Sichuan Neo-life Stem Cell Biotech Inc. |
Table 16 | Stem cell services of Shandong Qilu Stem Cell Engineering Co., Ltd. |
Table 17 | Stem cell services of Beijing Cord Blood Bank |
Table 18 | Administrative and Strategic Planning of Enterprises to VIPs |